FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19186411000001109: Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2338301000001113 Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2338321000001118 Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has unit of administration drop true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Is a Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter conventional release eye solution true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has active ingredient Dorzolamide false Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release eye solution true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has specific active ingredient Dorzolamide hydrochloride true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release eye drops false Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has dispensed dose form Drops dose form false Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dorzolamide true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release eye drops true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has basis of strength substance Dorzolamide true Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Has unit of administration drop false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) 5 ml Has AMP True Dorzolamide 20mg/ml eye drops (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start